IL10 and Dengue hemorrhagic fever: Of the cytokines evaluated, IL-10 was significantly higher in patients with severe COVID-19 pneumonia and in those who developed dengue hemorrhagic fever (DHF) compared with DF, indicating IL-10 as a biomarker of an altered antiviral response potentially contributing to disease severity [50].